Robert Charles Jahr insider trades
Open-market stock purchases and sales by Robert Charles Jahr, Chief Executive Officer at Outlook Therapeutics, Inc, from SEC Form 4 filings since Jul 1, 2025.
Track record: 0% of 1 scored buy are up 5% or more since purchase, averaging -49%.
Companies traded
- OTLK Outlook Therapeutics, Inc: 2 buys, last Aug 14, 2026
Get free alerts when Robert Charles Jahr files a new trade →